This site uses cookies to collect activity data and personalize content. By continuing to navigate this site, you agree to allow us to collect information using cookies. Learn more about how we care for your data in our privacy notice.

Accept

PATH Resources

Our online catalog indexes publications, presentations, and related resources for peers in our field.

1914 Resources
1914 Resources
1914 Resources
    Date
  1. COVID-19 has disrupted the delivery of essential services worldwide, including in places that are already battling other epidemics. This brief describes how the USAID/Afya Ziwani project in Western Kenya adapted the implementation of DREAMS programming, which provides HIV prevention services for adolescent girls and young women, to ensure continuity of services during the COVID-19 pandemic.
    Published: November 2020
    Type: Resource Page
  2. Cryptosporidiosis has been recognized as one of the leading causes of morbidity and mortality from diarrhea in children under 5 years of age in low-resource settings. Despite the magnitude and significance of the problem, only a single drug is approved to treat Cryptosporidium infection, and new therapies are urgently needed.The third Symposium on Innovative Therapeutics for Cryptosporidium puts the spotlight on Crypto. Similar to the first two meetings hosted by PATH in San Francisco, California (2016) and Seattle, Washington (2018), this convening assembles leading researchers to present and discuss the current state of work on Crypto— from early discovery to clinical development and commercialization, veterinary medicine, diagnostics, and vaccines. Our goal is to share research, highlight opportunities for collaboration, and spark innovation toward making new and improved therapies a reality. This document summarizes the event's scientific program.
    Published: November 2020
    Type: Resource Page
  3. A reliable supply chain is often referred to as the “backbone” of a health system. In addition to meeting the demand for drugs and medical supplies, it serves to safeguard a country’s investments in health commodities, which is particularly important as countries ramp up efforts to work toward universal health coverage.The aim of this Journey of the Pill assessment is to identify strengths and inefficiencies in the supply chain in Ghana. It builds on PATH’s earlier supply chain assessment in Kenya. Further defining the journey of medicines will help inform the Ministry of Health and other stakeholders of future actions to strengthen commodity security for noncommunicable diseases.
    Published: November 2020
    Type: Resource Page
  4. The results of a continuing collaboration between PATH and Quansys Biosciences
    Published: November 2020
    Type: Resource Page
  5. The Program for the Advancement of Malaria Outcomes (PAMO) is a flagship malaria program for the President’s Malaria Initiative (PMI), a US government initiative, in Zambia. PAMO helps the Government of the Republic of Zambia (GRZ) accelerate progress toward eliminating local malaria infection and disease. Implemented by PATH in partnership with Jhpiego and the Broadreach Institute for Training and Education (widely known as BRITE), PAMO supports the GRZ at the national level through the National Malaria Elimination Programme and in four high burden provinces: Luapula, Muchinga, Eastern, and Northern.Using the national harmonized malaria workplan, coordination meetings, and the malaria scorecard, PAMO supported partner coordination, program management, and resource mobilization efforts.
    Published: October 2020
    Type: Resource Page
Load more